13F HOLDINGS REPORT
Octagon Capital Advisors LP
Quarter ended Q1 2025 · Filed May 15, 2025 · Accession 0001839435-25-000004
Total Value
$516.8M
Positions
35
Other Managers
0
Confidential Omitted
No
Holdings (35)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | NUVATION BIO INC | SNDX | 27,330,800 | $48.1M | 9.31% |
| 2 | APELLIS PHARMACEUTICALS INC | COGT | 2,094,000 | $45.8M | 8.86% |
| 3 | DIANTHUS THERAPEUTICS INC | MAZE | 2,341,667 | $42.5M | 8.22% |
| 4 | ARRIVENT BIOPHARMA INC | DNTH | 2,059,387 | $38.1M | 7.37% |
| 5 | TREVI THERAPEUTICS INC | 89157D105 | 3,322,000 | $20.9M | 4.04% |
| 6 | CENTESSA PHARMACEUTICALS PLC | GOSS | 1,425,000 | $20.5M | 3.97% |
| 7 | GOSSAMER BIO INC | 60255C885 | 18,350,000 | $20.2M | 3.91% |
| 8 | OCULAR THERAPEUTIX INC | TSHA | 2,425,000 | $17.8M | 3.44% |
| 9 | MIND MEDICINE MINDMED INC | CATX | 3,018,000 | $17.7M | 3.42% |
| 10 | COGENT BIOSCIENCES INC | KLRS | 2,763,000 | $16.6M | 3.20% |
| 11 | KALVISTA PHARMACEUTICALS INC | NGNE | 1,370,000 | $15.8M | 3.06% |
| 12 | TAYSHA GENE THERAPIES INC | APGE | 10,700,000 | $14.9M | 2.88% |
| 13 | NUVATION BIO INC | SRRK | 7,900,000 | $13.9M | 2.69% |
| 14 | VERONA PHARMA PLC | HUMAW | 217,264 | $13.8M | 2.67% |
| 15 | TOURMALINE BIO INC | VRDN | 905,000 | $13.8M | 2.66% |
| 16 | MERUS N V | PHVS | 308,000 | $13.0M | 2.51% |
| 17 | PHARVARIS N V | 89157D105 | 769,815 | $12.1M | 2.34% |
| 18 | MOONLAKE IMMUNOTHERAPEUTICS | OCUL | 296,000 | $11.6M | 2.24% |
| 19 | SYNDAX PHARMACEUTICALS INC | UNCY | 904,000 | $11.1M | 2.15% |
| 20 | ATYR PHARMA INC | CRBP | 3,552,000 | $10.7M | 2.08% |
| 21 | SCHOLAR ROCK HOLDING CORP | 925050106 | 329,000 | $10.6M | 2.05% |
| 22 | VERASTEM INC | IBRX | 1,720,000 | $10.4M | 2.01% |
| 23 | CENTESSA PHARMACEUTICALS PLC | HLXC | 600,000 | $8.6M | 1.67% |
| 24 | REGULUS THERAPEUTICS INC | TRVI | 4,637,076 | $8.1M | 1.57% |
| 25 | ARS PHARMACEUTICALS INC | VSTM | 625,000 | $7.9M | 1.52% |
| 26 | ABIVAX SA | CNTA | 1,230,000 | $7.7M | 1.49% |
| 27 | ERASCA INC | N5749R100 | 5,136,795 | $7.0M | 1.36% |
| 28 | VIRIDIAN THERAPEUTICS INC | CAPR | 450,000 | $6.1M | 1.17% |
| 29 | CORBUS PHARMACEUTICALS HLDGS | KALV | 1,115,000 | $5.9M | 1.15% |
| 30 | UNICYCIVE THERAPEUTICS INC | ATYR | 10,000,000 | $5.7M | 1.11% |
| 31 | MAZE THERAPEUTICS INC | NUVB | 468,000 | $5.2M | 1.00% |
| 32 | PERSPECTIVE THERAPEUTICS INC | ERAS | 2,250,000 | $4.8M | 0.93% |
| 33 | KALARIS THERAPEUTICS INC | NUVB | 481,000 | $3.9M | 0.75% |
| 34 | NEUROGENE INC | 75915K309 | 303,000 | $3.5M | 0.69% |
| 35 | HELIX ACQUISITION CORP II | MLTX | 250,000 | $2.8M | 0.55% |